Cargando…

Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy

BACKGROUND: Blood cultures are considered the gold standard to distinguish bacteremia from non-bacteremic systemic inflammation. In current clinical practice, bacteraemia is considered unlikely if blood cultures have been negative for 48–72 hours. Modern BC systems have reduced this time-to-positivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambregts, Merel M. C., Bernards, Alexandra T., van der Beek, Martha T., Visser, Leo G., de Boer, Mark G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314566/
https://www.ncbi.nlm.nih.gov/pubmed/30601829
http://dx.doi.org/10.1371/journal.pone.0208819
_version_ 1783384119473864704
author Lambregts, Merel M. C.
Bernards, Alexandra T.
van der Beek, Martha T.
Visser, Leo G.
de Boer, Mark G.
author_facet Lambregts, Merel M. C.
Bernards, Alexandra T.
van der Beek, Martha T.
Visser, Leo G.
de Boer, Mark G.
author_sort Lambregts, Merel M. C.
collection PubMed
description BACKGROUND: Blood cultures are considered the gold standard to distinguish bacteremia from non-bacteremic systemic inflammation. In current clinical practice, bacteraemia is considered unlikely if blood cultures have been negative for 48–72 hours. Modern BC systems have reduced this time-to-positivity (TTP), questioning whether the time frame of 48–72 hrs is still valid. This study investigates the distribution of TTP, the probability of blood culture positivity after 24 hours, and identifies clinical predictors of prolonged TTP. METHODS: Adult patients with monomicrobial bacteremia in an academic hospital were included retrospectively over a three-year period. Clinical data were retrieved from the medical records. Predictors of TTP >24 hours were determined by uni- and multivariate analyses. The residual probability of bacteremia was estimated for the scenario of negative BCs at 24 hours after bedside collection. RESULTS: The cohort consisted of 801 patients, accounting for 897 episodes of bacteremia. Mean age was 65 years (IQR 54–73), 534 (59.5%) patients were male. Median TTP was 15.7 (IQR 13.5–19.3) hours. TTP was ≤24 hours in 85.3% of episodes. Antibiotic pre-treatment (adjusted OR 1.77; 95%CI 1.14–2.74, p<0.01) was independently associated with prolonged TTP. The probability of bacteremia, if BC had remained negative for 24 hours, was 1.8% (95% CI 1.46–2.14). CONCLUSION: With adequate hospital logistics, the probability of positive blood cultures after 24 hours of negative cultures was low. Combined with clinical reassessment, knowledge of this low probability may contribute to prioritization of the differential diagnosis and decisions on antimicrobial therapy. As a potential antibiotic stewardship tool, this strategy warrants further prospective investigation.
format Online
Article
Text
id pubmed-6314566
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63145662019-01-11 Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy Lambregts, Merel M. C. Bernards, Alexandra T. van der Beek, Martha T. Visser, Leo G. de Boer, Mark G. PLoS One Research Article BACKGROUND: Blood cultures are considered the gold standard to distinguish bacteremia from non-bacteremic systemic inflammation. In current clinical practice, bacteraemia is considered unlikely if blood cultures have been negative for 48–72 hours. Modern BC systems have reduced this time-to-positivity (TTP), questioning whether the time frame of 48–72 hrs is still valid. This study investigates the distribution of TTP, the probability of blood culture positivity after 24 hours, and identifies clinical predictors of prolonged TTP. METHODS: Adult patients with monomicrobial bacteremia in an academic hospital were included retrospectively over a three-year period. Clinical data were retrieved from the medical records. Predictors of TTP >24 hours were determined by uni- and multivariate analyses. The residual probability of bacteremia was estimated for the scenario of negative BCs at 24 hours after bedside collection. RESULTS: The cohort consisted of 801 patients, accounting for 897 episodes of bacteremia. Mean age was 65 years (IQR 54–73), 534 (59.5%) patients were male. Median TTP was 15.7 (IQR 13.5–19.3) hours. TTP was ≤24 hours in 85.3% of episodes. Antibiotic pre-treatment (adjusted OR 1.77; 95%CI 1.14–2.74, p<0.01) was independently associated with prolonged TTP. The probability of bacteremia, if BC had remained negative for 24 hours, was 1.8% (95% CI 1.46–2.14). CONCLUSION: With adequate hospital logistics, the probability of positive blood cultures after 24 hours of negative cultures was low. Combined with clinical reassessment, knowledge of this low probability may contribute to prioritization of the differential diagnosis and decisions on antimicrobial therapy. As a potential antibiotic stewardship tool, this strategy warrants further prospective investigation. Public Library of Science 2019-01-02 /pmc/articles/PMC6314566/ /pubmed/30601829 http://dx.doi.org/10.1371/journal.pone.0208819 Text en © 2019 Lambregts et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lambregts, Merel M. C.
Bernards, Alexandra T.
van der Beek, Martha T.
Visser, Leo G.
de Boer, Mark G.
Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy
title Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy
title_full Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy
title_fullStr Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy
title_full_unstemmed Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy
title_short Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy
title_sort time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314566/
https://www.ncbi.nlm.nih.gov/pubmed/30601829
http://dx.doi.org/10.1371/journal.pone.0208819
work_keys_str_mv AT lambregtsmerelmc timetopositivityofbloodculturessupportsearlyreevaluationofempiricbroadspectrumantimicrobialtherapy
AT bernardsalexandrat timetopositivityofbloodculturessupportsearlyreevaluationofempiricbroadspectrumantimicrobialtherapy
AT vanderbeekmarthat timetopositivityofbloodculturessupportsearlyreevaluationofempiricbroadspectrumantimicrobialtherapy
AT visserleog timetopositivityofbloodculturessupportsearlyreevaluationofempiricbroadspectrumantimicrobialtherapy
AT deboermarkg timetopositivityofbloodculturessupportsearlyreevaluationofempiricbroadspectrumantimicrobialtherapy